Avid Bioservices Inc (CDMO)

[Bungler]

"We provide evidence that the small molecule [LJ001] binds to both cellular and viral membranes, but its preferential ability to inactivate viral membranes comes from its ability to exploit the biogenic reparative ability of metabolically active cells versus static viral membranes," he said. "That is, at antiviral concentrations, any damage it does to the cell's membrane can be repaired, while damage done to static viral membranes, which have no inherent regenerative capacity, is permanent and irreversible."

So unlike Bavi, which attacks only the enveloped viral membrane, LJ001 attacks everything, and relies on the normal metabolic repairing function of a normal cell to repair the damage done to it by LJ001. Bavi would appear to be superior in this respect.